FROZEN-SECTION EVALUATION OF DONOR LIVERS BEFORE TRANSPLANTATION

被引:139
作者
MARKIN, RS
WISECARVER, JL
RADIO, SJ
STRATTA, RJ
LANGNAS, AN
HIRST, K
SHAW, BW
机构
[1] UNIV NEBRASKA, MED CTR, DEPT SURG, OMAHA, NE 68198 USA
[2] UNIV NEBRASKA, MED CTR, DEPT PREVENT & STRESS MED, OMAHA, NE 68198 USA
关键词
D O I
10.1097/00007890-199312000-00025
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Frozen section examination was performed on 385 donor livers before transplantation. Exclusion criteria were applied to the donor livers examined to exclude potentially dysfunctional livers. The exclusion criteria included the following: severe macrovesicular steatosis, ischemic necrosis, prominent chronic portal inflammation, prominent periductular fibrosis, granulomatous inflammation, bridging fibrosis, and malignancy. Twenty-seven of the 385 donor livers examined were excluded before transplantation. The following histologic features were present in the excluded livers: severe steatosis (22), ischemic necrosis (2), portal inflammation (1), and periductular fibrosis (2). Steatosis was present in 51 of the 385 (13.25%) organs examined, including 22 of the donor organs excluded before transplantation. Twenty-nine livers with mild to moderate steatosis were implanted into size and blood type-matched recipients. Indicators of allograft function (prothrombin time and bilirubin) and damage (aspartate aminotransferase and alanine aminotransferase) were measured daily for the first 10 days after transplant. There was no statistically significant difference between the group of nonfat livers and donor livers containing mild steatosis. Statistically significant higher posttransplant serum alanine aminotransferase and prothrombin time levels were present in the patients with livers implanted with mild versus moderate steatosis. The 1-year survival rate for patients receiving fatty versus nonfatty donor livers was not statistically different (Kaplan-Meier, P=0.592). No significant differences were found in the clinical and laboratory characteristics of donors whose organs were implanted compared with the clinical and laboratory characteristics of donors whose organs were excluded. The primary nonfunction rate after applying the exclusion criteria was 1.4%, which is a significant decrease compared with our primary nonfunction rate of 8.5% before using frozen section examination. Frozen section examination is useful in excluding donor organs which may become dysfunctional after transplantation.
引用
收藏
页码:1403 / 1409
页数:7
相关论文
共 24 条
[1]  
Starzl T.E., Hakala T.R., Rosenthal J.T., Denny D., Donors for liver transplantation, Pediatrics, 71, 5, (1983)
[2]  
Van Thiel D.H., Schade R.R., Hakala T.R., Starzl T.E., Denny D., Liver procurement for orthotopic transplantation: An analysis of the Pittsburgh experience, Hepatology, 4, 1, (1984)
[3]  
Starzl T.E., Hakala T.R., Shaw B.W., Et al., A flexible procedure for multiple cadaveric organ procurement, Surg Gynecol Obstet, 158, 3, (1984)
[4]  
Kakizoe S., Yanaga K., Starzl T.E., Demetris A.J., Evaluation of protocol before transplantation and after reperfusion biopsies from human orthotopic liver allografts: Considerations of preservation and early immunological injury, Hepatology, 11, (1990)
[5]  
Todo S., Nery J., Yanaga K., Podesta L., Gordon R.D., Starzl T.E., Extended preservation of human liver grafts with UW solution, JAMA, 261, (1989)
[6]  
Shaw B.W., Wood R.P., Improved results with retransplantation of the liver, Transplant Proc, 2407, (1989)
[7]  
Paulsen A.W., Brajtbord D., Klintmalm G.B., Ramsey M.A., Swygert T.H., Valek T.R., Intraoperative measurements related to subsequent hepatic graft failure, Transplant Proc, 2337, (1989)
[8]  
Iwatsuki S., Rabin B.S., Shaw B.W., Starzl T.E., Liver transplantation against T cell positive warm crossmatches, Transplant Proc, 16, (1984)
[9]  
Gordon R.D., Fung J.J., Markus B., Et al., The antibody crossmatch in liver transplantation, Surgery, 100, (1986)
[10]  
Moore S.B., Wiesner R.H., Perkind J.D., Nagorney D.M., Sterioff S., Krom R., A positive lymphocyte crossmatch and major histocompatibility complex matching do not predict early rejection of liver transplants in patients treated with cyclosporine, Transplant Proc, 2345, (1987)